NDC product
Dextromethorphan Polistirex Extended-Release
NDC 65162-700 · Amneal Pharmaceuticals LLC
Key facts
| Product NDC | 65162-700 |
|---|---|
| Proprietary name | Dextromethorphan Polistirex Extended-Release |
| Nonproprietary name | Dextromethorphan Polistirex |
| Substances | DEXTROMETHORPHAN HYDROBROMIDE |
| Dosage form | SUSPENSION |
| Route | ORAL |
| Labeler | Amneal Pharmaceuticals LLC |
| Product type | HUMAN OTC DRUG |
| Marketing category | ANDA |
| Application number | ANDA203133 |
| Pharmacologic classes | Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA] |
| Marketing start | Aug 1, 2017 |
| Listing certified through | Dec 31, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: